Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Nephrology

Pharmacology/kinetics

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

New England Journal of Medicine | Apr 18, 2019 Pharmacology/kinetics

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease

Kidney International | Apr 13, 2019 Pharmacology/kinetics

Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial

PLoS Medicine | Apr 12, 2019 Pharmacology/kinetics

Cocaine use and pre-exposure prophylaxis: Adherence, care engagement, and kidney function

Journal of Acquired Immune Deficiency Syndromes | Apr 12, 2019 Pharmacology/kinetics

Kidney dysfunction does not contribute significantly to antiretroviral therapy modification in treatment-naive PLWH receiving initial ART

Journal of Acquired Immune Deficiency Syndromes | Apr 12, 2019 Pharmacology/kinetics

Rate of correction of hypernatremia and health outcomes in critically ill patients

Clinical Journal of the American Society of Nephrology | Apr 11, 2019 Pharmacology/kinetics

Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: A prospective study using bioimpedance spectroscopy

Cardiovascular Diabetology | Apr 11, 2019 Pharmacology/kinetics

Rivaroxaban, a direct factor Xa inhibitor, ameliorates hypertensive renal damage through inhibition of the inflammatory response mediated by protease-activated receptor pathway

Journal of the American Heart Association | Apr 11, 2019 Pharmacology/kinetics

Veverimer vs placebo in patients with metabolic acidosis associated with chronic kidney disease: A multicentre, randomised, double-blind, controlled, phase 3 trial

The Lancet | Apr 10, 2019 Pharmacology/kinetics

Significance of content of the reticulocyte hemoglobin in the management of renal anemia

Blood Purification | Apr 08, 2019 Pharmacology/kinetics

« Prev 1 … 44 45 46 47 48 … 77 Next »

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease

Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial

Cocaine use and pre-exposure prophylaxis: Adherence, care engagement, and kidney function

Kidney dysfunction does not contribute significantly to antiretroviral therapy modification in treatment-naive PLWH receiving initial ART

Rate of correction of hypernatremia and health outcomes in critically ill patients

Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: A prospective study using bioimpedance spectroscopy

Rivaroxaban, a direct factor Xa inhibitor, ameliorates hypertensive renal damage through inhibition of the inflammatory response mediated by protease-activated receptor pathway

Veverimer vs placebo in patients with metabolic acidosis associated with chronic kidney disease: A multicentre, randomised, double-blind, controlled, phase 3 trial

Significance of content of the reticulocyte hemoglobin in the management of renal anemia

MIP: Snake Bite Management: Dr Surajit Giri

Therapeutic Effects of Bromelain: A Comprehensive Review

Anaemia: Types and Management

Neurological Emergencies: Recognising Essential Signs: MCQ challenge

Fluoride & its Administration

Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease

Octreotide-LAR in later-stage autosomal dominant polycystic kidney disease (ALADIN 2): A randomized, double-blind, placebo-controlled, multicenter trial

Cocaine use and pre-exposure prophylaxis: Adherence, care engagement, and kidney function

Kidney dysfunction does not contribute significantly to antiretroviral therapy modification in treatment-naive PLWH receiving initial ART

Rate of correction of hypernatremia and health outcomes in critically ill patients

Effect of SGLT2 inhibitors on body composition, fluid status and renin–angiotensin–aldosterone system in type 2 diabetes: A prospective study using bioimpedance spectroscopy

Rivaroxaban, a direct factor Xa inhibitor, ameliorates hypertensive renal damage through inhibition of the inflammatory response mediated by protease-activated receptor pathway

Veverimer vs placebo in patients with metabolic acidosis associated with chronic kidney disease: A multicentre, randomised, double-blind, controlled, phase 3 trial

Significance of content of the reticulocyte hemoglobin in the management of renal anemia

MIP: Snake Bite Management: Dr Surajit Giri

Therapeutic Effects of Bromelain: A Comprehensive Review

Anaemia: Types and Management

Neurological Emergencies: Recognising Essential Signs: MCQ challenge

Fluoride & its Administration

Select Specialty

Select Topic